ru-28362 has been researched along with s6c sarafotoxin in 1 studies
| Studies (ru-28362) | Trials (ru-28362) | Recent Studies (post-2010) (ru-28362) | Studies (s6c sarafotoxin) | Trials (s6c sarafotoxin) | Recent Studies (post-2010) (s6c sarafotoxin) |
|---|---|---|---|---|---|
| 175 | 0 | 3 | 595 | 3 | 37 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Funder, JW; Provencher, PH; Saltis, J | 1 |
1 other study(ies) available for ru-28362 and s6c sarafotoxin
| Article | Year |
|---|---|
Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells.
Topics: Aldosterone; Androstanols; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Cells, Cultured; Endothelin Receptor Antagonists; Endothelins; Glucocorticoids; Hypertension; Imidazoles; Losartan; Male; Mifepristone; Muscle, Smooth, Vascular; Peptides, Cyclic; Rats; Rats, Inbred SHR; Receptor, Endothelin A; Receptor, Endothelin B; Receptors, Endothelin; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Tetrazoles; Viper Venoms | 1995 |